Contact this trialFirst, we need to learn more about you.
Anti-inflammatory
Vascepa for Community-Acquired Pneumonia
Recruiting1 awardPhase 3
Ottawa, Ontario
This trial aims to see if a medication called Vascepa can reduce inflammation in the arteries of adults with Community-Acquired Pneumonia (CAP). Participants will either take Vascepa or
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service